News

The current COVID-19 pandemic has raised a number of issues related to the role and importance of psychiatrists compared with medical colleagues at this time of widespread illness and massive changes.

So begins this transformative journey to calm, peace, and tranquility in the face of a “coronacopia” of life upending challenges.

We often push thoughts of death far out of our awareness, but at the present time they unavoidably re-emerge. Can we learn something helpful from this?

Hearing about Coronavirus 2019 from opinionated and often unreliable sources made this 15-year-old more nervous than she needed to be.

A number of factors affect treatment adherence, including the therapeutic alliance, perceived perceived lack of control, risk of dependence on medications, stigma associated with medication use, and more.

Reports of verbal and physical aggression toward Chinese-American people have undeniable ripple effects, and if left unmonitored, turns into full-fledged Coronasiaphobia.

It’s been tornados, volcanoes, epidemics, and more. Now we have COVID-19; is the coronavirus here to stay?

On Thursday, March 26, the FDA granted authorization for SomrystTM, a prescription-only digital therapeutic for treatment of chronic insomnia in patients aged 22 years or older.

Take our brief survey and become a member of the Psychiatric Times Reader Reactor Panel.

As the COVID-19 pandemic continues to affect the country, SAMHSA and the DEA allow for flexibility in addressing the needs of patients with opioid use disorder.

Across the centuries, March has been an eventful month for the insanity defense on both sides of the Atlantic, and the McNaughten rule remains the prevalent standard to this day.

We thought it may be useful to have a frequent, but temporary (hopefully very temporary), series of brief pieces on the psychological aspects of the news, along with the occasional longer reflection pieces and podcasts.

The authors discuss abusive disciplinary practices that continue to this day despite considerable evidence to the contrary and share thoughts and implications for psychiatrists.

The COVID-19 pandemic has gained its place on the dark side of world history for a variety of reasons: sudden onset, speed of global transmission, mistakes in recognition and management, politically inspired neglect or minimizations.

I read Dear Provider in a letter from a health care company. Provider is a fine word, and I’ve always felt proud to provide for my family-but the company doesn’t know guys from Jersey are sensitive.

How can psychiatrists advise patients to manage their stress and to remain calm?

In 2009 I attended the United Nations Copenhagen Climate Conference. The general thought at the time was that it was the last best opportunity to keep the world from warming over 2 degrees centigrade.

How much progress has been made in the area of substance use disorders in the last 40 years?

Not that long ago I read a news story about three women who had reported that the psychiatrist treating them had insisted on sex.

College students are uniquely vulnerable to both everyday stressors and severe mental illness, and psychiatric symptoms among college students appear to be on the rise.

What can psychiatrists do to help their patients cope with self-quarantine and isolation practices? More in this podcast.

BPSD is associated with worse outcomes for patients with dementia. Management is not standardized, but protocols generally involve the treatment of underlying symptoms followed by the use of nonpharmacological management techniques and evidence-based pharmacotherapy for refractory BPSD.

What do we tell patients regarding the pandemic both in terms of office policies and preparations for self-isolation and quarantine as well as dealing with uncertainty?

These are hard times, but they get a little easier when we make the decision to unite and go through them together.

Psychiatrists are exploring ways to best serve their patients while complying with the medicolegal restrictions of the coronavirus. Here: approaches to best leverage telemedicine for patients with ADHD.

It is the final phase of God’s work of Creation. It’s a wonderful plan but with an inherent and dreadful problem.

Patient nonadherence to long-term antipsychotic therapy presents clinicians with unique unmet needs but also opportunities for promoting the realistic benefits of consistent treatment.

Many of us are now managing outpatients via phone and telecommunication. While the transition has been relatively painless, one can't help but wonder what the future will bring.